Cargando…
Lung cancer screening patient–provider discussion: Where do we stand and what are the associated factors?
OBJECTIVE: The primary objective of this study was to estimate the percentage of individuals possibly eligible for lung cancer screening that report having discussed screening with a health care provider. The secondary objective was to investigate the associated factors of having patient–provider lu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537245/ https://www.ncbi.nlm.nih.gov/pubmed/31205705 http://dx.doi.org/10.1177/2050312119854265 |
_version_ | 1783421964810977280 |
---|---|
author | Chalian, Hamid Khoshpouri, Pegah Iranmanesh, Arya M Mammarappallil, Joseph G Assari, Shervin |
author_facet | Chalian, Hamid Khoshpouri, Pegah Iranmanesh, Arya M Mammarappallil, Joseph G Assari, Shervin |
author_sort | Chalian, Hamid |
collection | PubMed |
description | OBJECTIVE: The primary objective of this study was to estimate the percentage of individuals possibly eligible for lung cancer screening that report having discussed screening with a health care provider. The secondary objective was to investigate the associated factors of having patient–provider lung cancer screening discussion. METHODS: Data from the Health Information National Trends Survey 2017 were used (n = 3217). Lung cancer screening eligibility was based on the criteria utilized by the Centers for Medicare and Medicaid Services. Gender, race, educational attainment, health insurance coverage, and usual source of health care were covariates. Current or former smokers ages 55–77 (n = 706) were considered potentially eligible for lung cancer screening (dependent variable). RESULTS: Only 12.24% of individuals potentially eligible for lung cancer screening report prior discussion regarding lung cancer screening with a health care provider. Being eligible for lung cancer screening based on Centers for Medicare and Medicaid Services eligibility criteria was positively associated with the odds of a patient–provider lung cancer screening discussion (odds ratio = 3.95, 95% confidence interval = 2.48–6.30). Unlike gender, race, education, or insurance coverage, a usual source of health care was positively associated with a patient–provider screening discussion (odds ratio = 2.48, 95% confidence interval = 1.31–4.70). CONCLUSION: Individuals potentially eligible for lung cancer screening are more likely to have screening discussions with a health care provider. Having a usual source of health care may increase the odds of such a discussion, while patients are not discriminated based on race, gender, education, and insurance coverage. However, the relatively low rate (12.24%) of reported patient–provider lung cancer screening discussion indicates that significant barriers still remain. |
format | Online Article Text |
id | pubmed-6537245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65372452019-06-14 Lung cancer screening patient–provider discussion: Where do we stand and what are the associated factors? Chalian, Hamid Khoshpouri, Pegah Iranmanesh, Arya M Mammarappallil, Joseph G Assari, Shervin SAGE Open Med Original Article OBJECTIVE: The primary objective of this study was to estimate the percentage of individuals possibly eligible for lung cancer screening that report having discussed screening with a health care provider. The secondary objective was to investigate the associated factors of having patient–provider lung cancer screening discussion. METHODS: Data from the Health Information National Trends Survey 2017 were used (n = 3217). Lung cancer screening eligibility was based on the criteria utilized by the Centers for Medicare and Medicaid Services. Gender, race, educational attainment, health insurance coverage, and usual source of health care were covariates. Current or former smokers ages 55–77 (n = 706) were considered potentially eligible for lung cancer screening (dependent variable). RESULTS: Only 12.24% of individuals potentially eligible for lung cancer screening report prior discussion regarding lung cancer screening with a health care provider. Being eligible for lung cancer screening based on Centers for Medicare and Medicaid Services eligibility criteria was positively associated with the odds of a patient–provider lung cancer screening discussion (odds ratio = 3.95, 95% confidence interval = 2.48–6.30). Unlike gender, race, education, or insurance coverage, a usual source of health care was positively associated with a patient–provider screening discussion (odds ratio = 2.48, 95% confidence interval = 1.31–4.70). CONCLUSION: Individuals potentially eligible for lung cancer screening are more likely to have screening discussions with a health care provider. Having a usual source of health care may increase the odds of such a discussion, while patients are not discriminated based on race, gender, education, and insurance coverage. However, the relatively low rate (12.24%) of reported patient–provider lung cancer screening discussion indicates that significant barriers still remain. SAGE Publications 2019-05-26 /pmc/articles/PMC6537245/ /pubmed/31205705 http://dx.doi.org/10.1177/2050312119854265 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Chalian, Hamid Khoshpouri, Pegah Iranmanesh, Arya M Mammarappallil, Joseph G Assari, Shervin Lung cancer screening patient–provider discussion: Where do we stand and what are the associated factors? |
title | Lung cancer screening patient–provider discussion: Where do we stand
and what are the associated factors? |
title_full | Lung cancer screening patient–provider discussion: Where do we stand
and what are the associated factors? |
title_fullStr | Lung cancer screening patient–provider discussion: Where do we stand
and what are the associated factors? |
title_full_unstemmed | Lung cancer screening patient–provider discussion: Where do we stand
and what are the associated factors? |
title_short | Lung cancer screening patient–provider discussion: Where do we stand
and what are the associated factors? |
title_sort | lung cancer screening patient–provider discussion: where do we stand
and what are the associated factors? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537245/ https://www.ncbi.nlm.nih.gov/pubmed/31205705 http://dx.doi.org/10.1177/2050312119854265 |
work_keys_str_mv | AT chalianhamid lungcancerscreeningpatientproviderdiscussionwheredowestandandwhataretheassociatedfactors AT khoshpouripegah lungcancerscreeningpatientproviderdiscussionwheredowestandandwhataretheassociatedfactors AT iranmanesharyam lungcancerscreeningpatientproviderdiscussionwheredowestandandwhataretheassociatedfactors AT mammarappalliljosephg lungcancerscreeningpatientproviderdiscussionwheredowestandandwhataretheassociatedfactors AT assarishervin lungcancerscreeningpatientproviderdiscussionwheredowestandandwhataretheassociatedfactors |